Literature DB >> 8415627

Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells.

J Wu1, J P Issa, J Herman, D E Bassett, B D Nelkin, S B Baylin.   

Abstract

Abnormal regional increases in DNA methylation, which have potential for causing gene inactivation and chromosomal instability, are consistently found in immortalized and tumorigenic cells. Increased DNA methyltransferase activity, which is also a characteristic of such cells, is a candidate to mediate these abnormal DNA methylation patterns. We now show that, in NIH 3T3 mouse fibroblasts, constitutive overexpression of an exogenous mouse DNA methyltransferase gene results in a marked increase in overall DNA methylation which is accompanied by tumorigenic transformation. These transformation changes can also be elicited by dexamethasone-inducible expression of an exogenous DNA methyltransferase gene. Our findings provide strong evidence that the increase in DNA methyltransferase activity associated with tumor progression could be a key step in carcinogenesis and provide a model system that can be used to further study this possibility.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8415627      PMCID: PMC47466          DOI: 10.1073/pnas.90.19.8891

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Microassay for DNA methyltransferase.

Authors:  R L Adams; A Rinaldi; C Seivwright
Journal:  J Biochem Biophys Methods       Date:  1991-01

2.  DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein.

Authors:  J Boyes; A Bird
Journal:  Cell       Date:  1991-03-22       Impact factor: 41.582

3.  De novo methylation of the MyoD1 CpG island during the establishment of immortal cell lines.

Authors:  P A Jones; M J Wolkowicz; W M Rideout; F A Gonzales; C M Marziasz; G A Coetzee; S J Tapscott
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

4.  High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines.

Authors:  F Antequera; J Boyes; A Bird
Journal:  Cell       Date:  1990-08-10       Impact factor: 41.582

5.  Molecular cloning, primary structure, and expression of the human growth factor-activatable Na+/H+ antiporter.

Authors:  C Sardet; A Franchi; J Pouysségur
Journal:  Cell       Date:  1989-01-27       Impact factor: 41.582

6.  The CpG dinucleotide and human genetic disease.

Authors:  D N Cooper; H Youssoufian
Journal:  Hum Genet       Date:  1988-02       Impact factor: 4.132

7.  Alternative chromatin structure at CpG islands.

Authors:  J Tazi; A Bird
Journal:  Cell       Date:  1990-03-23       Impact factor: 41.582

8.  Isolation of sequences that span the fragile X and identification of a fragile X-related CpG island.

Authors:  D Heitz; F Rousseau; D Devys; S Saccone; H Abderrahim; D Le Paslier; D Cohen; A Vincent; D Toniolo; G Della Valle
Journal:  Science       Date:  1991-03-08       Impact factor: 47.728

9.  Suppression of human colorectal carcinoma cell growth by wild-type p53.

Authors:  S J Baker; S Markowitz; E R Fearon; J K Willson; B Vogelstein
Journal:  Science       Date:  1990-08-24       Impact factor: 47.728

10.  Physical mapping across the fragile X: hypermethylation and clinical expression of the fragile X syndrome.

Authors:  M V Bell; M C Hirst; Y Nakahori; R N MacKinnon; A Roche; T J Flint; P A Jacobs; N Tommerup; L Tranebjaerg; U Froster-Iskenius
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

View more
  61 in total

1.  DNA methyl transferase 1: regulatory mechanisms and implications in health and disease.

Authors:  Sirano Dhe-Paganon; Farisa Syeda; Lawrence Park
Journal:  Int J Biochem Mol Biol       Date:  2011-01-30

Review 2.  Aberrant DNA methylation in human cancers.

Authors:  Wen Li; Bi-Feng Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-12-13

3.  Mitochondrial regulation of cancer associated nuclear DNA methylation.

Authors:  Cheng-hui Xie; Akihiro Naito; Takatsugu Mizumachi; Teresa T Evans; Michael G Douglas; Craig A Cooney; Chun-Yang Fan; Masahiro Higuchi
Journal:  Biochem Biophys Res Commun       Date:  2007-10-16       Impact factor: 3.575

4.  DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination.

Authors:  Zhanwen Du; Jing Song; Yong Wang; Yiqing Zhao; Kishore Guda; Shuming Yang; Hung-Ying Kao; Yan Xu; Joseph Willis; Sanford D Markowitz; David Sedwick; Robert M Ewing; Zhenghe Wang
Journal:  Sci Signal       Date:  2010-11-02       Impact factor: 8.192

Review 5.  Epigenetic changes in the myelodysplastic syndrome.

Authors:  Jean-Pierre Issa
Journal:  Hematol Oncol Clin North Am       Date:  2010-04       Impact factor: 3.722

6.  Sexually dimorphic DNA demethylation in the promoter of the Slp (sex-limited protein) gene in mouse liver.

Authors:  N Yokomori; R Moore; M Negishi
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

7.  Predicting aberrant CpG island methylation.

Authors:  F A Feltus; E K Lee; J F Costello; C Plass; P M Vertino
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-30       Impact factor: 11.205

8.  Infection with human immunodeficiency virus type 1 upregulates DNA methyltransferase, resulting in de novo methylation of the gamma interferon (IFN-gamma) promoter and subsequent downregulation of IFN-gamma production.

Authors:  J A Mikovits; H A Young; P Vertino; J P Issa; P M Pitha; S Turcoski-Corrales; D D Taub; C L Petrow; S B Baylin; F W Ruscetti
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

9.  Reduced rates of gene loss, gene silencing, and gene mutation in Dnmt1-deficient embryonic stem cells.

Authors:  M F Chan; R van Amerongen; T Nijjar; E Cuppen; P A Jones; P W Laird
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

10.  RFTS-deleted DNMT1 enhances tumorigenicity with focal hypermethylation and global hypomethylation.

Authors:  Bo-Kuan Wu; Szu-Chieh Mei; Charles Brenner
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.